141 related articles for article (PubMed ID: 18690847)
1. Celecoxib upregulates multidrug resistance proteins in colon cancer: lack of synergy with standard chemotherapy.
Gradilone A; Pulcinelli FM; Lotti LV; Trifirò E; Martino S; Gandini O; Gianni W; Frati L; Aglianò AM; Gazzaniga P
Curr Cancer Drug Targets; 2008 Aug; 8(5):414-20. PubMed ID: 18690847
[TBL] [Abstract][Full Text] [Related]
2. ATP-binding cassette C transporters in human pancreatic carcinoma cell lines. Upregulation in 5-fluorouracil-resistant cells.
Hagmann W; Jesnowski R; Faissner R; Guo C; Löhr JM
Pancreatology; 2009; 9(1-2):136-44. PubMed ID: 19077464
[TBL] [Abstract][Full Text] [Related]
3. Celecoxib attenuates 5-fluorouracil-induced apoptosis in HCT-15 and HT-29 human colon cancer cells.
Lim YJ; Rhee JC; Bae YM; Chun WJ
World J Gastroenterol; 2007 Apr; 13(13):1947-52. PubMed ID: 17461495
[TBL] [Abstract][Full Text] [Related]
4. Enhanced gemcitabine cytotoxicity with knockdown of multidrug resistance protein genes in human cholangiocarcinoma cell lines.
Yang J; Sontag D; Gong Y; Minuk GY
J Gastroenterol Hepatol; 2021 Apr; 36(4):1103-1109. PubMed ID: 33002234
[TBL] [Abstract][Full Text] [Related]
5. Induction of MRP5 and SMRP mRNA by adriamycin exposure and its overexpression in human lung cancer cells resistant to adriamycin.
Yoshida M; Suzuki T; Komiya T; Hatashita E; Nishio K; Kazuhiko N; Fukuoka M
Int J Cancer; 2001 Nov; 94(3):432-7. PubMed ID: 11745426
[TBL] [Abstract][Full Text] [Related]
6. Drug efflux transporter multidrug resistance-associated protein 5 affects sensitivity of pancreatic cancer cell lines to the nucleoside anticancer drug 5-fluorouracil.
Nambaru PK; Hübner T; Köck K; Mews S; Grube M; Payen L; Guitton J; Sendler M; Jedlitschky G; Rimmbach C; Rosskopf D; Kowalczyk DW; Kroemer HK; Weiss FU; Mayerle J; Lerch MM; Ritter CA
Drug Metab Dispos; 2011 Jan; 39(1):132-9. PubMed ID: 20930123
[TBL] [Abstract][Full Text] [Related]
7. [Correlation of chemosensitivity measured by histoculture drug response assay to expression of multidrug resistance genes and proteins in gastric cancer].
Yuan SQ; Zhou ZW; Liang YJ; Fu LW; Chen G; Keshari RP; Zhang LY
Ai Zheng; 2009 Apr; 28(4):337-43. PubMed ID: 19622290
[TBL] [Abstract][Full Text] [Related]
8. Cyclooxygenase-independent down-regulation of multidrug resistance-associated protein-1 expression by celecoxib in human lung cancer cells.
Kang HK; Lee E; Pyo H; Lim SJ
Mol Cancer Ther; 2005 Sep; 4(9):1358-63. PubMed ID: 16170027
[TBL] [Abstract][Full Text] [Related]
9. Analysis of expression of cMOAT (MRP2), MRP3, MRP4, and MRP5, homologues of the multidrug resistance-associated protein gene (MRP1), in human cancer cell lines.
Kool M; de Haas M; Scheffer GL; Scheper RJ; van Eijk MJ; Juijn JA; Baas F; Borst P
Cancer Res; 1997 Aug; 57(16):3537-47. PubMed ID: 9270026
[TBL] [Abstract][Full Text] [Related]
10. Efflux protein expression in human retinal pigment epithelium cell lines.
Mannermaa E; Vellonen KS; Ryhänen T; Kokkonen K; Ranta VP; Kaarniranta K; Urtti A
Pharm Res; 2009 Jul; 26(7):1785-91. PubMed ID: 19384462
[TBL] [Abstract][Full Text] [Related]
11. Increased expression of an ATP-binding cassette superfamily transporter, multidrug resistance protein 2, in human colorectal carcinomas.
Hinoshita E; Uchiumi T; Taguchi K; Kinukawa N; Tsuneyoshi M; Maehara Y; Sugimachi K; Kuwano M
Clin Cancer Res; 2000 Jun; 6(6):2401-7. PubMed ID: 10873092
[TBL] [Abstract][Full Text] [Related]
12. Gene expression of CYP3A4, ABC-transporters (MDR1 and MRP1-MRP5) and hPXR in three different human colon carcinoma cell lines.
Pfrunder A; Gutmann H; Beglinger C; Drewe J
J Pharm Pharmacol; 2003 Jan; 55(1):59-66. PubMed ID: 12625868
[TBL] [Abstract][Full Text] [Related]
13. Mapping of multidrug resistance gene 1 and multidrug resistance-associated protein isoform 1 to 5 mRNA expression along the human intestinal tract.
Zimmermann C; Gutmann H; Hruz P; Gutzwiller JP; Beglinger C; Drewe J
Drug Metab Dispos; 2005 Feb; 33(2):219-24. PubMed ID: 15523049
[TBL] [Abstract][Full Text] [Related]
14. Expression and immunolocalization of the multidrug resistance proteins, MRP1-MRP6 (ABCC1-ABCC6), in human brain.
Nies AT; Jedlitschky G; König J; Herold-Mende C; Steiner HH; Schmitt HP; Keppler D
Neuroscience; 2004; 129(2):349-60. PubMed ID: 15501592
[TBL] [Abstract][Full Text] [Related]
15. Lamin B, caspase-3 activity, and apoptosis induction by a combination of HMG-CoA reductase inhibitor and COX-2 inhibitors: a novel approach in developing effective chemopreventive regimens.
Swamy MV; Cooma I; Reddy BS; Rao CV
Int J Oncol; 2002 Apr; 20(4):753-9. PubMed ID: 11894121
[TBL] [Abstract][Full Text] [Related]
16. Expression of drug resistance proteins Pgp, MRP1, MRP3, MRP5 and GST-pi in human glioma.
Calatozzolo C; Gelati M; Ciusani E; Sciacca FL; Pollo B; Cajola L; Marras C; Silvani A; Vitellaro-Zuccarello L; Croci D; Boiardi A; Salmaggi A
J Neurooncol; 2005 Sep; 74(2):113-21. PubMed ID: 16193381
[TBL] [Abstract][Full Text] [Related]
17. Celecoxib and curcumin synergistically inhibit the growth of colorectal cancer cells.
Lev-Ari S; Strier L; Kazanov D; Madar-Shapiro L; Dvory-Sobol H; Pinchuk I; Marian B; Lichtenberg D; Arber N
Clin Cancer Res; 2005 Sep; 11(18):6738-44. PubMed ID: 16166455
[TBL] [Abstract][Full Text] [Related]
18. COX-2 independent induction of cell cycle arrest and apoptosis in colon cancer cells by the selective COX-2 inhibitor celecoxib.
Grösch S; Tegeder I; Niederberger E; Bräutigam L; Geisslinger G
FASEB J; 2001 Dec; 15(14):2742-4. PubMed ID: 11606477
[TBL] [Abstract][Full Text] [Related]
19. Characterization of the transport of nucleoside analog drugs by the human multidrug resistance proteins MRP4 and MRP5.
Reid G; Wielinga P; Zelcer N; De Haas M; Van Deemter L; Wijnholds J; Balzarini J; Borst P
Mol Pharmacol; 2003 May; 63(5):1094-103. PubMed ID: 12695538
[TBL] [Abstract][Full Text] [Related]
20. Multidrug resistance proteins MRP3, MRP1, and MRP2 in lung cancer: correlation of protein levels with drug response and messenger RNA levels.
Young LC; Campling BG; Cole SP; Deeley RG; Gerlach JH
Clin Cancer Res; 2001 Jun; 7(6):1798-804. PubMed ID: 11410522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
